Form 4: AtriCure COO Douglas J. Seith Reports Stock Transactions

AtriCure's Chief Operating Officer, Douglas J. Seith, reports acquisition and disposal of company stock related to restricted stock and performance share awards.

Summary

• Douglas J. Seith, the Chief Operating Officer of AtriCure, Inc., filed a Form 4 detailing changes in beneficial ownership of the company's stock.
• On March 1, 2025, Seith acquired 32,266 shares of common stock through a Restricted Stock Award under the 2023 Stock Incentive Plan, with one-third of the shares vesting annually over three years.
• On the same date, he also acquired 12,120 shares through the vesting and release of a Performance Share Award under the same plan, meeting the required company performance goals and service period.
• Seith disposed of 15,050 shares to satisfy tax withholding obligations related to the vesting of previously acquired restricted stock and performance share awards at a price of $38.74 per share.
• Following these transactions, Seith beneficially owns 183,563 shares of AtriCure common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine stock transactions related to compensation and tax obligations. There's no indication of unusual or concerning activity.

Positives

• The vesting of performance share awards suggests that the company met certain performance goals.

Negatives

• The disposal of shares to cover tax obligations reduces Seith's overall holdings, although this is a common practice.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

• Stock-based compensation is a common practice among publicly traded companies, particularly in the technology and healthcare sectors, to align management's interests with those of shareholders.
• Vesting schedules for restricted stock awards typically range from three to five years, with annual or quarterly vesting increments.
• Performance share awards are often tied to specific financial or operational metrics, such as revenue growth, profitability, or product development milestones.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they primarily reflect internal compensation mechanisms.

Key Dates